RxDoctor Payments Data

George Yared, MD

Gastroenterology · Tifton, GANPI 1790786226

Payments from drug & device makers

$12,279in general payments, 2019–2025

Across 170 payments — averaging $72.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$10K
  • Takeda Pharmaceuticals U.S.A., Inc.$476
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$250
  • Covidien LP$220
  • Johnson & Johnson$198
  • Endogastric Solutions, Inc$161
  • plus $779 from 14 others

What the payments were for

  • Speaking & faculty fees$9,00073%
  • Travel & lodging$3553%
  • Food & beverage$2,92424%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,279 in reported general payments places this provider in the 80th percentile of 492 gastroenterology providers in Georgia.

See all gastroenterology providers in Georgia

Medicare billing

Part B allowed, 2024
$115,414
Medicare patients
548
Services billed
829

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GattexTeduglutide12$537,605
CreonLipase/Protease/Amylase163$450,238
StelaraUstekinumab15$409,981
LinzessLinaclotide53$46,595
Dexlansoprazole DrDexlansoprazole48$16,467
MovantikNaloxegol Oxalate30$16,114
MotegrityPrucalopride Succinate12$8,448
Esomeprazole Magnesium120$5,195
Mesalamine ErMesalamine13$4,874
Pantoprazole Sodium395$4,781
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates68$4,124
AprisoMesalamine12$3,147
Omeprazole164$3,147
Lubiprostone33$2,585
Dicyclomine Hcl98$2,137

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Gattex, Motegrity$476$546,05424 claims
AbbVieCreon, Linzess$10,195$496,833216 claims
Johnson & JohnsonStelara$198$409,98115 claims
Redhill Biopharma Inc.Movantik$13$16,11430 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCApriso$250$3,14712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 492 gastroenterology providers in Georgia.

Other gastroenterology in Tifton

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →